Burden of bipolar depression: Impact of disorder and medications on quality of life

CNS Drugs

Volumn 22, Issue 5, 2008, Pages 389-406

  Michalak, Erin E ^a   Murray, Greg ^b   Young, Allan H ^a   Lam, Raymond W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Bipolar depression; Bipolar disorders; Quality of life

Indexed keywords

FLUOXETINE PLUS OLANZAPINE; LITHIUM; OLANZAPINE; PLACEBO; QUETIAPINE;

BIPOLAR DEPRESSION; CHRONIC DISEASE; CLINICAL TRIAL; DEPRESSION; HUMAN; HYPOMANIA; MANIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

BIPOLAR DISORDER; HUMANS; QUALITY OF LIFE;

EID: 41949121998     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200822050-00003     Document Type: Review

References (103)

1. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59 (6): 530-7
2. Judd LL, Schettler PJ, Akiskal HS, et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 2003; 6 (2): 127-37
3. Post RM, Nolen WA, Kupka RW, et al. The Stanley Foundation Bipolar Network: I. Rationale and methods. Br J Psychiatry 2001; 41 Suppl.: S169-76
4. Leverich GS, Post RM. Life charting of affective disorders. CNS Spectrums 1998; 3: 21-37
5. Post RM, Leverich GS, Altshuler LL, et al. An overview of recent findings of the Stanley Foundation Bipolar Network (part I). Bipolar Disord 2003; 5 (5): 310-9
6. Altshuler LL, Post RM, Black DO, et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry 2006; 67 (10): 1551-60
7. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors. Global Burden of Disease Study. Lancet 1997; 349 (9063): 1436-42
8. US Department of Health, Education and Welfare. Medical practice project: a state of the service report for the office of the assistant secretary for the US Dept of Health, Education and Welfare [policy research]. Washington, DC: US Department of Health, Education and Welfare, 1979
9. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276 (4): 293-9
10. Angst J, Cassano G. The mood spectrum: improving the diagnosis of bipolar disorder. Bipolar Disord 2005; 7 Suppl. 4: 4-12
11. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50 (2-3): 143-51
12. Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness: 1991. Soc Psychiatry Psychiatr Epidemiol 1995; 30 (5): 213-9
13. Suppes T, Kelly DI, Perla JM. Challenges in the management of bipolar depression. J Clin Psychiatry 2005; 66 Suppl. 5: 11-6
14. Matza LS, Rajagopalan KS, Thompson CL, et al. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. J Clin Psychiatry 2005; 66 (11): 1432-40
15. McCombs JS, Ahn J, Tencer T, et al. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. J Affect Disord 2007; 97 (1-3): 171-9
16. Hirschfeld RM, Vornik LA. Recognition and diagnosis of bipolar disorder. J Clin Psychiatry 2004; 65 Suppl. 15: 5-9
17. Hankin BL, Fraley RC, Lahey BB, et al. Is depression best viewed as a continuum or discrete category? A taxometric analysis of childhood and adolescent depression in a population-based sample. J Abnorm Psychol 2005; 114 (1): 96-110
18. Cuellar AK, Johnson SL, Winters R. Distinctions between bipolar and unipolar depression. Clin Psychol Rev 2005; 25 (3): 307-39
19. Schweitzer I, Maguire K, Ng C. Should bipolar disorder be viewed as manic disorder? Implications for bipolar depression. Bipolar Disord 2005; 7 (5): 418-23
20. Murray G, Goldstone E, Cunningham E. Personality and the predisposition(s) to bipolar disorder: heuristic benefits of a two-dimensional model. Bipolar Disord 2007; 9 (5): 453-61
21. Michalak EE, Murray GW, Young AH, et al. Quality of life impairment in bipolar disorder. In: Ritsner MS, Awad AG, editors. Quality of life impairment in schizophrenia, mood and anxiety disorders: from brain functions to clinical practice. Dordrecht: Springer, 2007
22. Kurs R, Farkas H, Ritsner M. Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls. Qual Life Res 2005; 14 (2): 433-40
23. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163 (2): 217-24
24. Dilsaver SC, Chen YW, Swann AC, et al. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 1997; 73 (1-2): 47-56
25. Lam D, Wong G. Prodromes, coping strategies and psychological interventions in bipolar disorders. Clin Psychol Rev 2005; 25 (8): 1028-42
26. Keller MB, Lavori PW, Coryell W, et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986; 255 (22): 3138-42
27. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 2003; 64 (6): 680-90
28. Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002; 63 (9): 807-11
29. Yatham LN, Lecrubier Y, Fieve RR, et al. Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disord 2004; 6 (5): 379-85
30. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30 (6): 473-83
31. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psych 1967; 6: 278-96
32. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-35
33. Keck Jr PE. Defining and improving response to treatment in patients with bipolar disorder. J Clin Psychiatry 2004; 65 Suppl. 15: 25-9
34. Colom F, Vieta E. A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients. Bipolar Disord 2004; 6 (6): 480-6
35. Harvey PD. Defining and achieving recovery from bipolar disorder. J Clin Psychiatry 2006; 67 Suppl. 9: 14-8
36. Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49 (10): 761-8
37. Altshuler L, Mintz J, Leight K. The life functioning questionnaire (LFQ): a brief, gender-neutral scale assessing functional outcome. Psychiatry Res 2002; 112 (2): 161-82
38. Leon AC, Solomon DA, Mueller TI, et al. The range of impaired functioning tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med 1999; 29 (4): 869-78
39. Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000; 17 (1): 13-35
40. The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41 (10): 1403-9
41. Namjoshi MA, Buesching DP. A review of the health-related quality of life literature in bipolar disorder. Qual Life Res 2001; 10 (2): 105-15
42. Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 2004; 20 (2): 139-54
43. Revicki DA, Matza LS, Flood E, et al. Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics 2005; 23 (6): 583-94
44. Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes 2005; 3: 72
45. Russo J, Roy-Byrne P, Reeder D, et al. Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity. J Nerv Ment Dis 1997; 185 (3): 166-75
46. Zhang H, Wisniewski SR, Bauer MS, et al. Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Compr Psychiatry 2006; 47 (3): 161-8
47. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003; 53 (11): 1028-42
48. Endicott J, Nee J, Harrison W, et al. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 1993; 29 (2): 321-6
49. Arnold LM, Witzeman KA, Swank ML, et al. Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. J Affect Disord 2000; 57 (1-3): 235-9
50. ten Have M, Vollebergh W, Bijl R, et al. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2002; 68 (2-3): 203-13
51. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann 1988; 11: 51-62
52. Berlim MT, Pargendler J, Caldieraro MA, et al. Quality of life in unipolar and bipolar depression: are there significant differences? J Nerv Ment Dis 2004; 192 (11): 792-5
53. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28 (3): 551-8
54. Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh: E and S Livingstone, 1921
55. Morgan VA, Mitchell PB, Jablensky AV. The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders. Bipolar Disord 2005; 7 (4): 326-37
56. Krabbendam L, Arts B, van Os J, et al. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res 2005; 80 (2-3): 137-49
57. Martinez-Aran A, Penades R, Vieta E, et al. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom 2002; 71 (1): 39-46
58. Chand PK, Mattoo SK, Sharan P. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis. Psychiatry Clin Neurosci 2004; 58 (3): 311-8
59. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1997; 154 (1): 99-105
60. Ferrans CE, Powers MJ. Psychometric assessment of the Quality of Life Index. Res Nurs Health 1992; 15 (1): 29-38
61. Dell'Osso L, Pini S, Cassano GB, et al. Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features. Bipolar Disord 2002; 4 (5): 315-22
62. Ghaemi SN, Stoll AL, Pope Jr HG. Lack of insight in bipolar disorder: the acute manic episode. J Nerv Ment Dis 1995; 183 (7): 464-7
63. Goldberg JF, Harrow M. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis. J Affect Disord 2005; 89 (1-3): 79-89
64. Leidy NK, Palmer C, Murray M, et al. Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder: psychometric performance of four self-report measures. J Affect Disord 1998; 48 (2-3): 207-14
65. Ozer S, Ulusahin A, Batur S, et al. Outcome measures of interepisode bipolar patients in a Turkish sample. Soc Psychiatry Psychiatr Epidemiol 2002; 37 (1): 31-7
66. Tsevat J, Keck PE, Hornung RW, et al. Health values of patients with bipolar disorder. Qual Life Res 2000; 9 (5): 579-86
67. Vojta C, Kinosian B, Glick H, et al. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2001; 42 (3): 190-5
68. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34 (3): 220-33
69. The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16 (3): 199-208
70. Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 2006; 188: 313-20
71. Robb JC, Cooke RG, Devins GM, et al. Quality of life and lifestyle disruption in euthymic bipolar disorder. J Psychiatr Res 1997; 31 (5): 509-17
72. Flanagan JC. A research approach to improving our quality of life. Am Psychol 1978; 33: 138-47
73. MacQueen GM, Young LT, Robb JC, et al. Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiatr Scand 2000; 101 (5): 374-81
74. Stewart AL, Hays RD, Ware Jr JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988; 26 (7): 724-35
75. Sierra P, Livianos L, Rojo L. Quality of life for patients with bipolar disorder: relationship with clinical and demographic variables. Bipolar Disord 2005; 7 (2): 159-65
76. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35 (7): 837-44
77. Cooke RG, Robb JC, Young LT, et al. Well-being and functioning in patients with bipolar disorder assessed using the MOS 20-ITEM short form (SF-20). J Affect Disord 1996; 39 (2): 93-7
78. Thase ME. Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 2005; 13 (5): 257-71
79. Gao K, Calabrese JR. Newer treatment studies for bipolar depression. Bipolar Disord 2005; 7 Suppl. 5: 13-23
80. Revicki DA, Paramore LC, Sommerville KW, et al. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. J Clin Psychiatry 2003; 64 (3): 288-94
81. Calabrese JR, Keck PE, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162 (7): 1351-60
82. Shi L, Namjoshi MA, Swindle R, et al. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clin Ther 2004; 26 (1): 125-34
83. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy 1992; 22 (3): 307-19
84. Endicott J, Rajagopalan K, Minkwitz M, et al. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. Int Clin Psychopharmacol 2007; 22 (1): 29-37
85. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-9
86. Katschnig H, Freeman H, Sartorius N, editors. Quality of life in mental disorders. 2nd ed. Chichester: John Wiley and Sons, 1997
87. Kocsis JH, Zisook S, Davidson J, et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry 1997; 154 (3): 390-5
88. Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 1998; 59 (11): 608-19
89. Michalak EE, Yatham LN, Wan DD, et al. Perceived quality of life in patients with bipolar disorder: does group psychoeducation have an impact? Can J Psychiatry 2005; 50 (2): 95-100
90. Hlastala SA, Frank E, Mallinger AG, et al. Bipolar depression: an underestimated treatment challenge. Depress Anxiety 1997; 5 (2): 73-83
91. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152 (8): 1130-8
92. Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5 (6): 407-20
93. Namjoshi MA, Risser R, Shi L, et al. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. J Affect Disord 2004; 81 (3): 223-9
94. Shi L, Namjoshi MA, Zhang F, et al. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002; 17 (5): 227-37
95. Namjoshi MA, Rajamannar G, Jacobs T, et al. Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania: results from a randomized controlled trial. J Affect Disord 2002; 69 (1-3): 109-18
96. Tohen M, Goldberg JF, Arrillaga AMGP, et al. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 2003; 60 (12): 1218-26
97. Michalak EE, Yatham LN, Kolesar S, et al. Bipolar disorder and quality of life: a patient-centred perspective. Qual Life Res 2006; 15 (1): 25-37
98. Michalak EE, Yatham LN, Maxwell V, et al. The impact of bipolar disorder upon work functioning: a qualitative analysis. Bipolar Disord 2006; 9: 126-43
99. Orley J, Saxena S, Herrman H. Quality of life and mental illness: reflections from the perspective of the WHOQOL. Br J Psychiatry 1998; 172: 291-3
100. Vieta E, Gasto C, Otero A, et al. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 1997; 38 (2): 98-101
101. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60 (3): 261-9
102. Watson S, Gallagher P, Ritchie JC, et al. Hypothalamic pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004; 184: 496-502
103. Thompson JM, Gallagher P, Hughes JH, et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186: 32-40